TrialAmerican journal of clinical oncology2020

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.

Ross A Abrams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.